Accumulation of both interstitial myofibroblasts and excessive production of extracellular matrix proteins is a common pathway contributing to chronic kidney disease. In a number of tissues, activation of STAT3 (signal transducer and activator of transcription 3) increases expression of multiple profibrotic genes. Here, we examined the effect of a STAT3 inhibitor, S3I-201, on activation of renal interstitial fibroblasts and progression of renal fibrosis. Treatment of cultured rat renal interstitial fibroblasts with S3I-201 inhibited their activation, as evidenced by dose-and time-dependent blockade of a-smooth muscle actin and fibronectin expression. In a mouse model of renal interstitial fibrosis induced by unilateral ureteral obstruction, STAT3 was activated, and administration of S3I-201 attenuated both this activation and extracellular matrix protein deposition following injury. S3I-201 reduced infiltration of the injured kidney by inflammatory cells and suppressed the injuryinduced expression of fibronectin, a-smooth muscle actin, and collagen type-1 proteins, as well as the expression of multiple cytokines. Furthermore, S3I-201 inhibited proliferation and induced apoptosis preferentially in renal interstitial fibroblasts of the obstructed kidney. Thus, our results suggest that increased STAT3 activity mediates activation of renal interstitial fibroblasts and the progression of renal fibrosis. Inhibition of STAT3 signaling with S3I-201 may hold therapeutic potential for fibrotic kidney diseases.
Accumulation of both interstitial myofibroblasts and excessive production of extracellular matrix proteins is a common pathway contributing to chronic kidney disease. In a number of tissues, activation of STAT3 (signal transducer and activator of transcription 3) increases expression of multiple profibrotic genes. Here, we examined the effect of a STAT3 inhibitor, S3I-201, on activation of renal interstitial fibroblasts and progression of renal fibrosis. Treatment of cultured rat renal interstitial fibroblasts with S3I-201 inhibited their activation, as evidenced by dose-and time-dependent blockade of a-smooth muscle actin and fibronectin expression. In a mouse model of renal interstitial fibrosis induced by unilateral ureteral obstruction, STAT3 was activated, and administration of S3I-201 attenuated both this activation and extracellular matrix protein deposition following injury. S3I-201 reduced infiltration of the injured kidney by inflammatory cells and suppressed the injuryinduced expression of fibronectin, a-smooth muscle actin, and collagen type-1 proteins, as well as the expression of multiple cytokines. Furthermore, S3I-201 inhibited proliferation and induced apoptosis preferentially in renal interstitial fibroblasts of the obstructed kidney. Thus, our results suggest that increased STAT3 activity mediates activation of renal interstitial fibroblasts and the progression of renal fibrosis. Inhibition of STAT3 signaling with S3I-201 may hold therapeutic potential for fibrotic kidney diseases.
Renal tubulointerstitial fibrosis is the final common pathway in end-stage renal disease and is characterized by aberrant activation and growth of the renal fibroblasts.
1,2 The activation of interstitial fibroblasts to become a-smooth muscle actin (a-SMA)-positive myofibroblasts is the key step in the evolution of chronic kidney disease (CKD). Therefore, targeting the signaling pathway(s) that mediate the activation of myofibroblasts may be a way to attenuate the progression of renal fibrosis.
Among the signaling pathways reported to be associated with activation of renal interstitial fibroblasts, 1, 3 transforming growth factor-b1 (TGF-b1) signaling has a major role in this process. [4] [5] [6] TGF-b1 induces its biological effects by interaction with TGF-b receptor type-I (TbRI), type-II (TbRII), and type-III (TbRIII). 7, 8 Upregulation of TGF-b1 and TGF-b receptors has been observed in various forms of chronic renal fibrotic diseases in animal models and in humans. 4, 9 In addition, accumulation of inflammatory cells and expression of some proinflammatory mediators such as tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b), intercellular adhesion molecule-1 (ICAM-1), and monocyte chemotactic protein-1 (MCP-1) also contribute to the development of renal fibrosis in human and animal models of CKD. 3, [10] [11] [12] Signal transducer and activator of transcription 3 (STAT3) has been reported to induce expression of multiple genes, including TGF-b1. [13] [14] [15] STAT3 belongs to a family comprised of seven members (STAT1-4, STAT5a, STAT5b, and STAT6) and mediates various cellular functions, including cell survival and proliferation. 16, 17 In response to numerous growth factors and cytokines such as TGF-b1, 18 plateletderived growth factor, 19, 20 and IL-6, 21, 22 STAT3 is activated by tyrosine phosphorylation at tyrosine 705 through Janus kinases. Phosphorylated STAT3 forms dimers and then translocates to the nucleus, where it directly binds to the DNA sequence and regulates expression of target genes.
However, the functional role of STAT3 in activation of renal fibroblasts and development of renal interstitial fibrosis has not been examined in vivo.
Recently, S3I-201, a novel selective inhibitor of STAT3, has been synthesized and used to treat tumors. S3I-201 preferentially inhibits STAT3 DNA-binding activity and diminishes STAT3 tyrosine phosphorylation. 24 In this study, we evaluated the therapeutic effect of S3I-201 on the activation of renal interstitial fibroblasts in vitro using rat NRK-49F cells, a rat renal interstitial fibroblast line, and the progression of renal fibrosis in a murine model of the fibrotic kidney induced by UUO injury. Furthermore, we investigated the effect of S3I-201 on the expression of some cytokines associated with the development of progressive renal fibrosis. Myofibroblasts are active fibroblasts characterized by expression of a-SMA and fibronectin. 3 To understand whether STAT3 activation is required for activation of renal interstitial fibroblasts, we examined the effect of S3I-201 on expression of a-SMA and fibronectin in NRK-49F cells. As shown in Figure 1a -d, both a-SMA and fibronectin were highly expressed in NRK-49F cells, indicating that the cultured renal interstitial fibroblasts are phenotypically myofibroblasts. Incubation of cells with S3I-201 dramatically decreased the expression of a-SMA and fibronectin in a dose-and time-dependent manner, suggesting that STAT3 mediates activation of renal interstitial fibroblasts. The STATs are activated by tyrosine phosphorylation. 25, 26 p-STAT3 and p-STAT5, but not p-STAT1, were constitutively expressed in cultured NRK-49F cells. Treatment with S3I-201 dose-dependently inhibited the expression of p-STAT3 with a complete inhibition at 100 mM (Figure 1e and f). S3I-201 treatment did not affect STAT5 phosphorylation, but increased expression of p-STAT1 in a dose-dependent manner (Supplementary Figure S1 ). These data suggest that S3I-201 is a highly selective inhibitor of STAT3 and is able to block expression of the constitutively activated STAT3 in Figure 1 | Effect of S3I-201 on the expression of a-smooth muscle actin (a-SMA) and fibronectin. Cultured NRK-49F cells were treated with S3I-201 for the indicated concentrations for 24 h (a) or 3 h (e), or exposed to 50 mM S3I-201 for the indicated time period (c). Cell lysates were subjected to immunoblot analysis using antibodies to a-SMA, fibronectin, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Representative immunoblots from three or more experiments are shown. Expression levels of the indicated proteins were quantified by densitometry and normalized with GAPDH (b, d). Activated signal transducer and activator of transcription 3 (STAT3) was depicted with p-STAT3/STAT3 ratio (f). Data are means ± s.e.m. Significant P-values reflecting differences are indicated over the bars (*Po0.05; **Po0.01).
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renal interstitial fibroblasts. Furthermore, STAT3 may negatively regulate STAT1 activation. As recent studies have documented that both STAT1 and STAT5 have a role in suppression of tissue fibrosis, in contrast to STAT3, 27, 28 increased expression of p-STAT1 and preservation of p-STAT5 may be beneficial to the alleviation of renal fibrosis after injury.
Downregulation of STAT3 by siRNA inhibits expression of a-SMA and fibronectin in cultured renal interstitial fibroblasts
To confirm the role of STAT3 in mediating a-SMA and fibronectin expression in NRK-49F cells, small interfering RNA (siRNA) targeting STAT3 was transfected to NRK-49F cells by electroporation to downregulate STAT3, and expression of a-SMA and fibronectin was examined by immunoblot analysis. Figure 2 shows that knockdown of STAT3 decreased expression of a-SMA and fibronectin in NRK-49F cells (Figure 2 ). These data support our conclusions that STAT3 is critically involved in activation of cultured renal interstitial fibroblasts.
STAT3 phosphorylation and expression in the obstructive kidney
On the basis of the above observation, we hypothesized that STAT3 has an essential role in mediating the development of renal interstitial fibrosis in vivo. To test this hypothesis, we first examined the activation and expression of STAT3 in obstructive nephropathy, a model of predominantly tubulointerstitial lesions that are characterized by accumulation and activation of myofibroblasts. 29 As shown in Figure 3a and b, the basal level of STAT3, but not p-STAT3, was observed in sham-operated kidneys. UUO injury caused STAT3 tyrosine phosphorylation, which evolves in two waves: the first on day 1 and the second on day 7. STAT3 tyrosine phosphorylation then remained elevated until at least 14 days after UUO injury. Whereas p-STAT3 expression declined on day 3 after UUO injury, total STAT3 expression was still upregulated at this point. On day 7, expression of STAT3 reached its maximum and kept this level until at least 14 days after UUO injury.
Previous work indicates that p-STAT3 is preferentially expressed in myofibroblasts in rat kidneys subjected to UUO injury. 23 To determine whether this is also the case in the mouse model of UUO, we performed double immunostaining for a-SMA and p-STAT3 in kidney tissue after UUO injury. Most of the cells localized to the interstitium stained for both a-SMA and p-STAT3, and a small number of cells stained only for a-SMA. Cells stained only for p-STAT3 were observed only occasionally (Figure 3d and e) . Therefore, these data illustrate that STAT3 is preferentially activated in renal interstitial fibroblasts after UUO injury.
S3I-201 inhibits STAT3 phosphorylation in the obstructive kidney
As an initial step toward understanding the role of STAT3 in renal fibrosis, we examined the effect of S3I-201 on the expression of p-STAT3 in the kidney following obstructive injury. Contralateral kidneys were used as controls. As shown in Figure 4 , daily administration of S3I-201 at 10 mg/kg largely suppressed STAT3 phosphorylation on day 7 and a small inhibition on day 14 after UUO (Supplementary Figure  S3) . Total STAT3 expression was not affected by this treatment at both time points. These data indicate that UUO injury induces both activation of STAT3 and upregulation of STAT3 protein, and that S3I-201 is an effective inhibitor of STAT3 activation without changing STAT3 protein levels. Furthermore, S3I-201 is more effective in inhibiting STAT3 activation in the early phase of obstructive nephropathy. The reason for the different effect of this inhibitor at the early and later time points is currently unknown, but may be associated with change in the signal responsible for STAT3 activation due to increased injury over time. Further studies are needed to address the mechanism that regulates STAT3 activation at different phases.
S3I-201 attenuates deposition of ECM components
An increase in extracellular matrix (ECM) is the major feature of renal fibrosis. 4, 30 To determine whether STAT3 activation is involved in the regulation of renal interstitial To further elucidate the role of STAT3 in fibroblast activation and production of a particular ECM protein, we examined the effect of S3I-201 on the expression of collagen type-1 and a-SMA, the hallmark of fibroblast activation, after UUO injury. 4 As indicated in Figure 6a -c, basal levels of a-SMA and abundant collagen type-1 were detected in the kidney tissue of sham-operated mice. UUO injury resulted in a marked increase in their expression. S3I-201 treatment inhibited a-SMA expression and also decreased collagen type-1 to the basal level in obstructive kidneys. Interestingly, S3I-201 did not affect the basal levels of collagen type-1 and a-SMA expression in control kidneys. In addition, we also examined the effect of S3I-201 on the expression of collagen type-1 at mRNA level and found that UUO injury also resulted in increased expression of collagen type-1 (Figure 6d ), whereas S3I-201 treatment attenuated this response. In contrast to those observations, administration Figure S4) . Therefore, increased collagen type-1 and a-SMA after UUO injury, rather than their basal levels, are regulated by STAT3. Furthermore, STAT3 does not have a role in regulation of b-catenin and snail, two transcriptional regulators involved in the epithelial-mesenchymal transition. 31, 32 We further examined the effect of S3I-201 on activation of renal interstitial fibroblasts on day 14 after UUO injury. S3I-201 at 10 mg/kg also decreased a-SMA and collagen type-1 expression at that time, but not to significant levels (Supplementary Figure S3) . Reduced effects of S3I-201 on activation of renal interstitial fibroblasts at the later time point is currently unclear and needs further investigations.
S3I-201 inhibits expression of fibronectin after obstructive injury
To determine whether S3I-201 administration inhibits other ECM proteins, we assessed the effect of S3I-201 on fibronectin expression by immunostaining and immunoblot analysis. Fibronectin staining showed increased expression of fibronectin after UUO injury. S3I-201 administration decreased its expression (Figure 7a-d) . Similar results were also obtained by immunoblot analysis of kidney tissue lysates (Figure 7e ). Densitometry analysis of immunoblot results showed a significant increase in the expression of fibronectin in the kidneys of mice following UUO, compared with control sham-operated mice. In contrast, fibronectin expression was blocked in mice treated with S3I-201 (Figure 7f ). These data, taken together with the inhibitory effect of S3I-201 on collagen type-1 expression, suggest that STAT3 is critically involved in the production of ECM proteins after UUO injury. 
S3I-201 decreases TGF-b1 and TbRII upregulation induced by obstructive injury
As increased expression of TGF-b1 and/or TGF-b receptors is found in almost all forms of kidney diseases with interstitial fibrosis, 4 we examined the effects of S3I-201 on the expression of TGF-b1 and three TGF-b receptors (type-I, type-II, and type-III) in obstructive kidneys using real-time PCR. Expression of TGF-b1 and TbRII was significantly increased in mice after obstructive injury, and administration of S3I-201 reduced their levels (Figure 8a and c) . In contrast, expression levels of TbRI and TbRIII were not changed after UUO injury compared with control groups (Figure 8b and  d) . Interestingly, S3I-201 still reduced the basal level of TbRIII, whereas TbRI expression at the basal level was not affected by this treatment. Similarly, S3I-201 significantly decreased expression of TGF-b1, TbRII, and TbRIII, but not of TbRI in cultured renal interstitial fibroblasts (Supplementary Figure S2) . In addition, we examined expression levels of TGF-b1 protein using the enzyme-linked immunosorbent assay (ELISA) assay and showed that S3I-201 also decreased expression of TGF-b1 protein in obstructive kidneys (Figure 8e ). These data indicate that STAT3 mediates expression of both TGF-b1 and its receptor, TbRII, in the obstructive kidney.
Effect of S3I-201 on leukocyte infiltration and expression of proinflammatory cytokines after obstructive injury
We also examined the effect of S3I-201 on leukocyte infiltration and expression of multiple proinflammatory cytokines, including TNF-a, IL-1b, MCP-1, and ICAM-1. Staining of kidney sections with naphthol-AS-D-chloroacetate esterase showed prominent interstitial infiltration of neutrophils and monocytes after obstructive injury. S3I-201 treatment reduced leukocyte infiltration to basal levels ( Figure 9 ). The expression levels of TNF-a, IL-1b, ICAM-1, and MCP-1 were also increased in obstructive kidneys. S3I-201 treatment reduced expression of TNF-a, IL-1b, and ICAM-1 mRNA, but did not affect UUO injury-induced MCP-1 mRNA expression (Figure 10a-d) . To verify these observations, we examined the effect of S3I-201 on the expression of TNF-a and IL-1b proteins using the ELISA assay. S3I-201 also significantly suppressed their expression at the protein levels (Figure 10e and f). These data suggest that STAT3 activity contributes to leukocyte infiltration and is selectively involved in the production of proinflammatory cytokines in UUO-induced renal fibrosis.
Effect of S3I-201 on proliferation and apoptosis of renal interstitial fibroblasts after obstructive injury
We further examined the effect of S3I-201 on apoptosis and proliferation of renal interstitial fibroblasts after UUO injury using the terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) assay and by evaluating cells for phosphohistone (Ser-10) positivity, respectively. Phosphorylation of histone H3 at this site specifically mark cells undergoing mitosis. 33, 34 As shown in Supplementary Figures S5 and S6, animals with UUO injury displayed a greater number of TUNEL-positive and p-histone H3-positive cells, predominantly in the renal interstitium. S3I-201 treatment resulted in increased apoptosis of interstitial cells and decreased their proliferation. S3I-201 administration did not induce apoptosis of renal tubular cells (Supplementary Figure S5b) . These data illustrate that UUO injury-induced STAT3 activation contributes to survival and proliferation of interstitial cells, most probably renal interstitial fibroblasts.
DISCUSSION
Using S3I-201, a selective inhibitor of STAT3, 24 we provided evidence that STAT3 activity is necessary for the activation and proliferation of renal interstitial fibroblasts and the destruction of the kidney. We have shown that S3I-201 treatment inhibits the expression of a-SMA and interstitial ECM proteins, decreases proliferation of renal interstitial fibroblasts, attenuates progression of renal fibrosis, and suppresses infiltration of leukocytes and expression of multiple inflammatory cytokines in obstructive nephropathy.
In this study, we observed that UUO injury induces STAT3 phosphorylation at tyrosine 705 in the fibrotic mouse kidney, as early as day 1, reaching a maximum level at day 7, and remaining elevated for 14 days after UUO injury. Further immunohistochemical analysis localized p-STAT3 in most tubulointerstitial cells expressing a-SMA (Figure 3 ). These observations correlate with the findings of Kuratsune et al., 23 indicating that p-STAT3 preferentially colocalizes with a-SMA in the tubulointerstitium in the rat kidney. The marked and persistent increase in activated STAT3 in the interstitial cells of fibrotic kidney suggests the importance of STAT3 in mediating activation of renal interstitial fibroblasts and progression of renal fibrosis following UUO injury. Indeed, inactivation of STAT3 by S3I-201 significantly attenuated the pathogenesis of renal fibrosis as described above. Furthermore, inhibition of STAT3 with either S3I-201 or its specific siRNA blocked the expression of a-SMA and fibronectin in cultured renal interstitial fibroblasts (Figures 1a-d and 2a-b) .
The STAT3 activation can be induced by multiple growth factors and cytokines such as TGF-b1, 18 platelet-derived growth factor, 19, 20 and IL-6, 21,22 that contribute to the development of renal fibrosis, 35, 36 and increased expression of activated STAT3 was detected in several kidney diseases associated with progressive fibrosis, including glomerulonephritis and diabetic nephropathy. 37, 38 Thus, we suggest that STAT3 may act as a common mediator in chronic renal damage. Consistent with our observations on the profibrotic role of STAT3 in the kidney, hyperactivated STAT3 has also been reported to be associated with chemically induced liver fibrosis 15 and scar formation after spinal cord injury. 39 Inhibition of STAT3 activation may elicit an antifibrotic effect by multiple mechanisms. As TGF-b1 signaling has a central role in a variety of fibrogenic processes such as fibroblast activation, and STAT3 is a known transcription factor, [4] [5] [6] 16 we examined the effect of S3I-201 on the expression of TGF-b1 and TGF-b receptors in the kidney after UUO. Our results clearly indicated that expression levels of TGF-b1 and TbRII mRNA were upregulated in the obstructed kidney, and S3I-201 treatment suppressed their expression (Figure 8a and c) . Furthermore, treatment with S3I-201 also suppressed the expression of TGF-b1 protein in the obstructed kidney (Figure 8e) . Thus, we suggest that S3I-201-elicited inhibition of myofibroblast activation is likely mediated by antagonizing TGF-b1 signaling through suppression of TGF-b1 and TbRII expression. Two potential STAT3-binding sites have been reported to exist in the promoter region of TGF-b1 and STAT3 activates promoter activity in vitro, suggesting that STAT3 may directly regulate TGF-b1 gene expression. 15 Progression of renal fibrosis is closely associated with the inflammatory response. We observed that administration of S3I-201 inhibited infiltration of neutrophils and monocytes and suppressed the expression of TNF-a, IL-1b, and ICAM-1, but not MCP-1, in the obstructed kidney. These results suggest that inhibition of inflammatory responses may be another mechanism by which S3I-201 attenuates renal fibrosis. As MCP-1 is a chemokine for monocytes, we also suggest that STAT3 may induce monocyte infiltration into sites of injury in the kidney through a mechanism that is not involved in MCP-1 expression. In addition to MCP-1, other chemokines such as RANTES, monocyte inflammatory protein-1a, and macrophage inflammatory protein are also associated with the progression of renal fibrosis. [40] [41] [42] It will be interesting to examine whether STAT3 diminishes monocyte infiltration by reducing expression of those chemokines. S3I-201 is a selective and potent inhibitor of constitutive activation of STAT3 DNA-binding and STAT3-mediated gene expression. 24 Unlike other commonly used STAT3 inhibitors such as AG490, which act on Janus kinases, the upstream activators of STAT3, and other STAT isoforms, [43] [44] [45] S3I-201 inhibits STAT3-STAT3 complex formation and STAT3 DNAbinding and transcriptional activities in cells that contain constitutively activated STAT3. 24 By binding to STAT3, S3I-201 may also prevent STAT3 protein from binding to the pTyr motifs of the receptor tyrosine kinases and subsequently block de novo phosphorylation by tyrosine kinases. 24 These properties are very important for the treatment of renal fibrosis, as recent studies using knockout mice showed that in contrast to STAT3, STAT1 and STAT5 have a role in abrogating liver and lung fibrosis after injury. 27, 28 Our results showed that S3I-201, at the concentration that blocked STAT3 phosphorylation, increased expression of p-STAT1 but did not affect that of p-STAT5 in NRK-49F cells (Supplementary Figure S1 ), suggesting that the resultant increased expression of p-STAT1 and preservation of p-STAT5 in renal interstitial fibroblasts after STAT3 inhibition may also be important for attenuating the progression of tissue fibrosis.
The expanded population of fibroblasts in the diseased kidney could result from an increase in proliferation and/or a decrease in cell death. 35, 46 Our results showed that administration of S3I-201 inhibited proliferation and promoted death in renal interstitial cells at day 7 after UUO injury ( Supplementary Figures S5 and S6) . In view of the fact that most of those cells are expressed with both a-SMA and STAT3, as shown in Figure 3d , we suggest that STAT3 may also mediate the progression of renal fibrosis through increasing survival and proliferation of renal interstitial fibroblasts. Consequently, inhibition of STAT3-mediated renal interstitial fibroblast proliferation and survival would be additional mechanisms for alleviating the development of renal interstitial fibrosis.
In summary, our results clearly show that inhibition of STAT3 with S3I-201 can suppress activation and proliferation, and induce death of renal interstitial fibroblasts. Furthermore, S3I-301 treatment inhibits excessive deposition of ECM and transcriptional expression of TGF-b1, TbRII, and several proinflammatory cytokines that are associated with progressive kidney diseases. Therefore, inhibition of the STAT3 signaling pathway by S3I-201 may provide a novel approach to prevent the development of nephropathy and attenuate the progression of renal fibrosis.
MATERIALS AND METHODS
Chemicals and antibodies S3I-201 was purchased from Calbiochem (La Jolla, CA, USA). Antibodies to STAT3, p-STAT1, p-STAT3, p-STAT5, and b-catenin were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-fibronectin was purchased from BD transduction Laboratory (Lexington, KY, USA). Primers were synthesized from Invitrogen (Carlsbad, CA, USA). STAT3 siRNA and silencer negative control siRNA were purchased from Invitrogen. Antibodies to a-SMA and a-tubulin, the naphthol-AS-D-chloroacetate esterase kit, and all other chemicals and blocks were obtained from Sigma (St Louis, MO, USA).
Cell culture and treatments NRK-49F cells were cultured in Dulbecco's modified Eagle's medium (Sigma-Aldrich) containing 10% fetal bovine serum, 0.5% penicillin and streptomycin in an atmosphere of 5% CO 2 and 95% air at 37 1C. described previously. 47 The contralateral kidneys were used as controls. To examine the efficacy of S3I-201 in renal fibrosis after UUO injury, S3I-201 (10 mg/kg) in 50 ml of dimethyl sulfoxide was intraperitoneally administered to mice immediately after ureter ligation and then given daily for 6 or 13 days. Mice were randomized into four groups with 6-7 mice in each group as follows: (1) sham injury with dimethyl sulfoxide as vehicle; (2) sham injury with S3I-201; (3) UUO injury with dimethyl sulfoxide; and (4) UUO injury with S3I-201.
Western blot analysis
Immunoblot analysis for NRK-49F cells and tissue samples was carried out according to our previous protocols. 47 Sirius red and immunofluorescent staining Sirius red and immunofluorescent staining was based on the procedure described in our previous studies. 47 Quantitative real-time PCR Real-time quantitative reverse transcriptase PCR amplifications were performed in 20 ml reactions ( Table 1 ). The amplification protocol was as follows: denaturation for 10 min and enzyme activation at 95 1C, 40 cycles of 95 1C Â 10 s, 59 1C Â 30 s, and 72 1C Â 20 s, followed by one-step annealing at 72 1C for 5 min. Relative mRNA abundance was determined from the ratios of specific mRNA to 18S ribosomal RNA measured in the same samples, and fold change was calculated relative to the group of sham-operated mice with vehicle treatment.
ELISA
Protein levels of TGF-b1, TNF-a, and IL-1b in kidney homogenates were determined using specific sandwich enzyme immunometric assay kits, ELISA Ready-SET-Go (eBioscience San Diego, CA, USA), as described previously. 48 The results were normalized by total protein content in kidney homogenates. In situ TUNEL assays The TUNEL staining was used to detect DNA strand breaks using a detection kit, according to the instructions provided by the manufacturer. The number of TUNEL-positive nuclei per field was evaluated in five fields per section and five sections per kidney.
Statistical analysis
All the experiments were conducted at least three times. Data depicted in graphs represent the mean ± s.e.m. for each group. Multiple means were compared using Tukey's test. The differences between two groups were determined by Student's t-test. Statistical significant difference between mean values was marked in each graph. Po0.05 is considered to be significant.
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